# Vortioxetine

## BrinteLLIX 10mg (Lundbeck)

| TAH Drug Code      | [OBRIN1](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OBRIN1)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Treatment of major depressive disorder (MDD).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Dosing             | Adult <65 years old: Initial 10mg QD PO. The dose can be increased up to 20mg or decreased to 5mg based on individual response. >=65 years and older: Initial 5mg QD PO. Caution is advised when using doses exceeding 10mg daily. Treatment should continue for at least 6 months after symptom relief to consolidate the antidepressant effect. Vortioxetine is administered orally and can be taken with or without food.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Contraindications  | Concomitant use with an MAOI (use within 14 days of discontinuing an MAOI used to treat psychiatric disorders or MAOI use within 21 days after vortioxetine discontinuation), or initiating linezolid or IV methylene blue in a patient receiving vortioxetine; increased risk of serotonin syndrome. Hypersensitivity to vortioxetine or any component of the product.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Adverse Effects    | >10%: Gastrointestinal: Nausea (21% to 32%) Genitourinary: Female sexual disorder (?2%; Arizona Sexual Experiences Scale: 22% to 34%), male sexual disorder (3% to 5%; Arizona Sexual Experiences Scale: 16% to 29%) 1% to 10%: Dermatologic: Pruritus (2% to 3%) Gastrointestinal: Constipation (5% to 6%), diarrhea (7% to 10%), flatulence (2% to 3%), vomiting (3% to 6%), xerostomia (7% to 8%) Nervous system: Abnormal dreams (2% to 3%), dizziness (8% to 9%) <1%: Endocrine & metabolic: Hyponatremia Nervous system: Hypomania, mania Frequency not defined: Cardiovascular: Flushing Gastrointestinal: Dysgeusia, dyspepsia Nervous system: Suicidal ideation, suicidal tendencies, vertigo Ophthalmic: Mydriasis Postmarketing: Dermatologic: Hyperhidrosis, skin rash, urticaria Endocrine & metabolic: Amenorrhea, hyperprolactinemia, weight gain Gastrointestinal: Acute pancreatitis Hypersensitivity: Hypersensitivity reaction (including anaphylaxis) Nervous system: Aggressive behavior, agitation, anosmia (including hyposmia), headache, hostility, irritability, outbursts of anger, restless leg syndrome, seizure, serotonin syndrome, withdrawal syndrome Neuromuscular & skeletal: Stress fracture Respiratory: Eosinophilic pneumonitis |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Lactation          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| More Info          | [UpToDate](https://www.uptodate.com/contents/vortioxetine-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |

